Form 8-K - Current report:
SEC Accession No. 0001096906-17-000499
Filing Date
2017-08-04
Accepted
2017-08-04 16:30:17
Documents
1
Period of Report
2017-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8K aoxing.htm 8-K 14705
  Complete submission text file 0001096906-17-000499.txt   16251
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-32674 | Film No.: 171008996
SIC: 2834 Pharmaceutical Preparations